Merck & Co., Inc. (MRK)
138.48
-4.89
(-3.41%)
USD |
NYSE |
Nov 18, 16:00
137.46
-1.02
(-0.74%)
After-Hours: 20:00
Merck Price : 138.48 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 143.32 | 144.89 | 142.31 | 143.37 | 7.270M |
| Nov 16, 2026 | 147.90 | 149.23 | 144.25 | 144.46 | 8.651M |
| Nov 13, 2026 | 147.31 | 147.99 | 145.24 | 147.76 | 6.508M |
| Nov 12, 2026 | 148.61 | 149.31 | 146.86 | 146.95 | 6.108M |
| Nov 11, 2026 | 146.61 | 147.62 | 145.30 | 147.18 | 6.414M |
| Nov 10, 2026 | 148.40 | 149.19 | 145.58 | 148.05 | 5.511M |
| Nov 09, 2026 | 148.37 | 148.80 | 146.52 | 148.76 | 7.566M |
| Nov 06, 2026 | 144.34 | 147.48 | 142.80 | 146.73 | 7.628M |
| Nov 05, 2026 | 152.00 | 153.37 | 146.54 | 146.94 | 11.55M |
| Nov 04, 2026 | 148.54 | 150.42 | 146.05 | 150.36 | 10.72M |
| Nov 03, 2026 | 147.02 | 147.62 | 143.47 | 144.67 | 8.894M |
| Nov 02, 2026 | 148.82 | 150.26 | 147.10 | 148.36 | 9.095M |
| Oct 30, 2026 | 149.55 | 151.35 | 147.40 | 149.52 | 12.35M |
| Oct 29, 2026 | 144.62 | 149.26 | 143.32 | 146.33 | 13.45M |
| Oct 28, 2026 | 140.00 | 142.40 | 139.21 | 140.93 | 8.240M |
| Oct 27, 2026 | 140.22 | 142.69 | 139.83 | 141.82 | 9.058M |
| Oct 26, 2026 | 145.89 | 146.61 | 139.93 | 140.61 | 13.10M |
| Oct 23, 2026 | 145.02 | 145.44 | 143.41 | 145.27 | 8.381M |
| Oct 22, 2026 | 151.05 | 154.02 | 144.07 | 147.24 | 19.03M |
| Oct 21, 2026 | 147.11 | 150.00 | 147.11 | 149.88 | 9.008M |
| Oct 20, 2026 | 146.29 | 149.36 | 146.12 | 148.30 | 9.924M |
| Oct 19, 2026 | 145.00 | 147.41 | 143.53 | 143.63 | 10.45M |
| Oct 16, 2026 | 146.96 | 147.80 | 145.61 | 145.95 | 11.23M |
| Oct 15, 2026 | 149.70 | 152.34 | 144.91 | 145.19 | 13.87M |
| Oct 14, 2026 | 143.10 | 148.16 | 142.66 | 147.37 | 9.808M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 273.98 |
| Eli Lilly & Co. | 1382.64 |
| Pfizer Inc. | 28.06 |
| Bristol Myers Squibb Co. | 59.57 |
| Abbott Laboratories | 104.50 |
Price Related Metrics
| PE Ratio | 141.42 |
| PS Ratio | 5.102 |
| Price to Book Value | 7.609 |
| Price to Free Cash Flow | 23.26 |
| Earnings Yield | 0.71% |
| Market Cap | 341.60B |
| Operating PE Ratio | 27.70 |
| Normalized PE Ratio | 46.35 |